Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Pfizer’s Experimental Drug Works in Ulcerative Colitis
Aug. 17, 2012
Pfizer’s experimental rheumatoid arthritis pill tofacitinib eased symptoms of patients with ulcerative colitis, an inflammatory bowel disease that affects 750,000 Americans, a company-sponsored study showed.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing